Skip to main content

Table 1 Characteristics of participants

From: Small leucine-rich proteoglycans (SLRPs) in the endometrium of polycystic ovary syndrome women: a pilot study

 

CONTROL (n = 10)

PCOS (n = 10)

p-value

Age, years

28.6 ± 2.0

29.6 ± 1.2

NS

Caucasian, n

5

6

NS

BMI, Kg/m2

27.49 ± 2.45

28.01 ± 3.19

NS

TT (ng/dL)

35.9 ± 11.7

83.09 ± 24.8

< 0.05*

DHEAS (mg/mL)

421.5 ± 52.1

520.4 ± 82.1

NS

TSH (μUI/mL)

2.8 ± 1.7

2.9 ± 1.6

NS

Insulin (μUI/mL)

8.8 ± 2.9

15.5 ± 3.5

< 0.05*

Glucose (mg/dL)

81.8 ± 8.6

89.2 ± 11.9

NS

17-OHP (mg/mL)

17.3 ± 8.4

18.3 ± 7.4

NS

FSH (mUI/ml)

5.0 ± 1.2

5.1 ± 1.1

NS

LH (mUI/ml)

5.9 ± 2.9

9.5 ± 3.8

< 0.05*

PRL (ng/dl)

10.8 (4.3–34.5)

11.4 (4.2–33.5)

NS

A (ng/mL)

2.2 ± 0.8

4.2 ± 1.3

< 0.05*

Tfree (pg/dl)

1.7 ± 0.40

2.1 ± 1.0

NS

  1. Data are expressed as median and standard deviation; BMI Body mass index, TT total testosterone, TSH thyroid stimulating hormone, Tfree free testosterone, A androstenedione, LH lutein hormone, FSH follicle-stimulating hormone, PRL prolactin, 17-OHP 17α-hydroxyprogesterone, DHEAS dehydroepiandrosterone sulfate, NS nonsignificant difference (p > 0.05). *Significance of P-value <0.05